• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绝经后类风湿关节炎的影像学关节破坏与全身性骨质疏松密切相关。

Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosis.

作者信息

Forsblad D'Elia H, Larsen A, Waltbrand E, Kvist G, Mellström D, Saxne T, Ohlsson C, Nordborg E, Carlsten H

机构信息

Department of Rheumatology and Inflammation Research, Göteborg University, Sweden.

出版信息

Ann Rheum Dis. 2003 Jul;62(7):617-23. doi: 10.1136/ard.62.7.617.

DOI:10.1136/ard.62.7.617
PMID:12810422
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1754591/
Abstract

OBJECTIVES

To investigate determinants of joint destruction and reduced bone mineral density (BMD) in postmenopausal women with active rheumatoid arthritis (RA) not treated with bisphosphonates or hormone replacement therapy and to evaluate if there are common markers of erosive disease and bone loss.

METHODS

BMD was measured using dual x ray absorptiometry and joint damage was examined by x ray examination according to the Larsen method in 88 patients with RA. Associations between BMD and Larsen score, and between demographic and disease related variables, including proinflammatory cytokines, HLA-DR4 epitopes, and markers of bone and cartilage turnover, were examined bivariately by simple and multiple linear regression analyses.

RESULTS

49/88 (56%) patients had osteoporosis in at least one site. Reduced BMD and increased joint destruction were associated with: at the forearm and femoral neck, high Larsen score, low weight, and old age (R(2)=0.381, p<0.001; R(2)=0.372, p<0.001, respectively); at the total hip, low weight, high Larsen score, and dose of injected glucocorticosteroids (R(2)=0.435, p<0.001); at the lumbar spine, low weight, reduced cartilage oligomeric matrix protein, and increased carboxyterminal propeptide of type I procollagen (R(2)=0.248, p<0.001). Larsen score was associated with long disease duration and increased C reactive protein (CRP) (R(2)=0.545, p<0.001).

CONCLUSIONS

Osteoporosis is common in postmenopausal patients with RA. Low weight and high Larsen score were strongly associated with BMD reduction. Increased CRP and long disease duration were determinants of erosive disease in postmenopausal women with RA. These findings indicate common mechanisms of local and generalised bone loss in RA.

摘要

目的

研究未接受双膦酸盐或激素替代疗法的绝经后活动性类风湿关节炎(RA)女性关节破坏和骨矿物质密度(BMD)降低的决定因素,并评估是否存在侵蚀性疾病和骨质流失的共同标志物。

方法

采用双能X线吸收法测量88例RA患者的BMD,并根据Larsen法通过X线检查评估关节损伤情况。通过简单和多元线性回归分析对BMD与Larsen评分之间以及人口统计学和疾病相关变量(包括促炎细胞因子、HLA - DR4表位以及骨和软骨转换标志物)之间的关联进行双变量检验。

结果

49/88(56%)的患者至少在一个部位存在骨质疏松。BMD降低和关节破坏增加与以下因素相关:在前臂和股骨颈,Larsen评分高、体重低和年龄大(R² = 0.381,p < 0.001;R² = 0.372,p < 0.001);在全髋关节,体重低、Larsen评分高和注射用糖皮质激素剂量(R² = 0.435,p < 0.001);在腰椎,体重低、软骨寡聚基质蛋白降低和I型前胶原羧基末端前肽增加(R² = 0.248,p < 0.001)。Larsen评分与病程长和C反应蛋白(CRP)升高相关(R² = 0.545,p < 0.001)。

结论

骨质疏松在绝经后RA患者中很常见。体重低和Larsen评分高与BMD降低密切相关。CRP升高和病程长是绝经后RA女性侵蚀性疾病的决定因素。这些发现表明RA中局部和全身性骨质流失存在共同机制。

相似文献

1
Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosis.绝经后类风湿关节炎的影像学关节破坏与全身性骨质疏松密切相关。
Ann Rheum Dis. 2003 Jul;62(7):617-23. doi: 10.1136/ard.62.7.617.
2
Bone mineral density by digital X-ray radiogrammetry is strongly decreased and associated with joint destruction in long-standing rheumatoid arthritis: a cross-sectional study.数字 X 射线射线照相术测定的骨矿物质密度明显降低,并与长期类风湿关节炎的关节破坏有关:一项横断面研究。
BMC Musculoskelet Disord. 2011 Oct 24;12:242. doi: 10.1186/1471-2474-12-242.
3
The relation between joint erosion and generalized osteoporosis and disease activity in patients with rheumatoid arthritis.类风湿关节炎患者关节侵蚀与全身性骨质疏松及疾病活动度之间的关系。
Rheumatol Int. 2006 Aug;26(10):896-9. doi: 10.1007/s00296-006-0104-9. Epub 2006 Apr 20.
4
Reduced bone mineral density in early rheumatoid arthritis is associated with radiological joint damage at baseline and after 2 years in women.早期类风湿性关节炎患者骨矿物质密度降低与女性患者基线及2年后的放射学关节损伤相关。
J Rheumatol. 2003 Dec;30(12):2590-6.
5
Changes in bone mineral density in premenopausal women with rheumatoid arthritis during a two-year follow-up.类风湿关节炎绝经前女性在两年随访期间骨密度的变化。
Joint Bone Spine. 2007 Oct;74(5):482-7. doi: 10.1016/j.jbspin.2007.01.021. Epub 2007 May 30.
6
The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.中国某郊区绝经后女性骨转换标志物25(OH)D和甲状旁腺激素水平及其与骨密度的关系
Osteoporos Int. 2017 Jan;28(1):211-218. doi: 10.1007/s00198-016-3692-6. Epub 2016 Jul 28.
7
Preferential reduction of bone mineral density at the femur reflects impairment of physical activity in patients with low-activity rheumatoid arthritis.低活动度类风湿关节炎患者的股骨骨密度优先减少反映了身体活动能力的受损。
Mod Rheumatol. 2010 Feb;20(1):69-73. doi: 10.1007/s10165-009-0242-5.
8
Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density.类风湿关节炎患者的骨密度:疾病严重程度与低骨密度之间的关系。
Ann Rheum Dis. 2004 Dec;63(12):1576-80. doi: 10.1136/ard.2003.016253.
9
Comparison of the effect of 18-month daily teriparatide administration on patients with rheumatoid arthritis and postmenopausal osteoporosis patients.18个月每日给予特立帕肽对类风湿性关节炎患者和绝经后骨质疏松症患者影响的比较。
Osteoporos Int. 2014 Dec;25(12):2755-65. doi: 10.1007/s00198-014-2819-x. Epub 2014 Aug 1.
10
Serum concentrations of formation (PINP) and resorption (Ctx) bone turnover markers in rheumatoid arthritis.类风湿关节炎患者血清形成(PINP)和吸收(Ctx)骨转换标志物浓度。
Rheumatol Int. 2009 Oct;29(12):1403-9. doi: 10.1007/s00296-009-0867-x. Epub 2009 Feb 15.

引用本文的文献

1
Traditional Chinese medicine in osteoporosis: from pathogenesis to potential activity.中医在骨质疏松症中的应用:从发病机制到潜在活性
Front Pharmacol. 2024 Apr 2;15:1370900. doi: 10.3389/fphar.2024.1370900. eCollection 2024.
2
Understanding the Role of Interleukin-6 (IL-6) in the Joint and Beyond: A Comprehensive Review of IL-6 Inhibition for the Management of Rheumatoid Arthritis.了解白细胞介素-6(IL-6)在关节及其他方面的作用:关于IL-6抑制治疗类风湿关节炎的综合综述。
Rheumatol Ther. 2020 Sep;7(3):473-516. doi: 10.1007/s40744-020-00219-2. Epub 2020 Jul 30.
3
Clinical utilities of quantitative ultrasound in osteoporosis associated with inflammatory rheumatic diseases.定量超声在炎症性风湿性疾病相关性骨质疏松症中的临床应用
Quant Imaging Med Surg. 2018 Feb;8(1):100-113. doi: 10.21037/qims.2018.02.02.
4
Senescent T-Cells Promote Bone Loss in Rheumatoid Arthritis.衰老 T 细胞促进类风湿关节炎的骨质流失。
Front Immunol. 2018 Feb 1;9:95. doi: 10.3389/fimmu.2018.00095. eCollection 2018.
5
Correlation between hand bone mineral density and joint destruction in established rheumatoid arthritis.已确诊类风湿关节炎患者手部骨密度与关节破坏之间的相关性
J Orthop. 2017 Aug 2;14(4):461-465. doi: 10.1016/j.jor.2017.07.010. eCollection 2017 Dec.
6
Selective oestrogen receptor modulators lasofoxifene and bazedoxifene inhibit joint inflammation and osteoporosis in ovariectomised mice with collagen-induced arthritis.选择性雌激素受体调节剂拉索昔芬和巴多昔芬可抑制胶原诱导性关节炎去卵巢小鼠的关节炎症和骨质疏松。
Rheumatology (Oxford). 2016 Mar;55(3):553-63. doi: 10.1093/rheumatology/kev355. Epub 2015 Sep 30.
7
Trabecular bone loss in collagen antibody-induced arthritis.胶原抗体诱导性关节炎中的小梁骨丢失
Arthritis Res Ther. 2015 Jul 25;17(1):189. doi: 10.1186/s13075-015-0703-5.
8
Estrogen regulates T helper 17 phenotype and localization in experimental autoimmune arthritis.雌激素在实验性自身免疫性关节炎中调节辅助性T细胞17表型和定位。
Arthritis Res Ther. 2015 Feb 13;17(1):32. doi: 10.1186/s13075-015-0548-y.
9
Bone remodelling markers in rheumatoid arthritis.类风湿关节炎中的骨重塑标志物
Mediators Inflamm. 2014;2014:484280. doi: 10.1155/2014/484280. Epub 2014 Apr 15.
10
Relation of interleukin-6 in rheumatoid arthritis patients to systemic bone loss and structural bone damage.类风湿关节炎患者白细胞介素-6 与全身骨丢失和结构性骨损伤的关系。
Rheumatol Int. 2013 Mar;33(3):697-703. doi: 10.1007/s00296-012-2375-7. Epub 2012 Apr 25.

本文引用的文献

1
Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial.低剂量泼尼松治疗早期活动类风湿关节炎患者:临床疗效、病情缓解特性及副作用:一项随机、双盲、安慰剂对照临床试验
Ann Intern Med. 2002 Jan 1;136(1):1-12. doi: 10.7326/0003-4819-136-1-200201010-00006.
2
The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis.类风湿关节炎病程中疾病活动度、关节破坏与功能能力之间的关系。
Arthritis Rheum. 2001 Sep;44(9):2009-17. doi: 10.1002/1529-0131(200109)44:9<2009::AID-ART349>3.0.CO;2-L.
3
Bone loss. Factors that regulate osteoclast differentiation: an update.骨质流失。调节破骨细胞分化的因素:最新进展。
Arthritis Res. 2000;2(6):451-456. doi: 10.1186/ar127. Epub 2000 Sep 6.
4
Physiologic role of interleukin-1 receptor antagonist.白细胞介素-1受体拮抗剂的生理作用。
Arthritis Res. 2000;2(4):245-8. doi: 10.1186/ar94. Epub 2000 May 19.
5
A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis.一项关于类风湿关节炎骨密度的多中心横断面研究。意大利类风湿关节炎骨量研究组。
J Rheumatol. 2000 Nov;27(11):2582-9.
6
Pathogenesis of bone erosions in rheumatoid arthritis.类风湿关节炎中骨侵蚀的发病机制。
Curr Opin Rheumatol. 2000 May;12(3):195-9. doi: 10.1097/00002281-200005000-00006.
7
Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register.类风湿关节炎女性患者的骨矿物质密度及骨质疏松症发生率:来自奥斯陆郡类风湿关节炎登记处394例患者的结果
Arthritis Rheum. 2000 Mar;43(3):522-30. doi: 10.1002/1529-0131(200003)43:3<522::AID-ANR7>3.0.CO;2-Y.
8
Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis.核因子κB受体激活剂配体/破骨细胞分化因子在类风湿关节炎滑膜细胞破骨细胞生成中的作用。
Arthritis Rheum. 2000 Feb;43(2):259-69. doi: 10.1002/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W.
9
Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor.类风湿性关节炎中的滑膜组织是破骨细胞分化因子的一个来源。
Arthritis Rheum. 2000 Feb;43(2):250-8. doi: 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P.
10
Postmenopausal osteoporosis is more related to hormonal aberrations than to lifestyle factors.绝经后骨质疏松症与激素异常的关系比与生活方式因素的关系更大。
Clin Endocrinol (Oxf). 1999 Oct;51(4):387-94. doi: 10.1046/j.1365-2265.1999.00776.x.